What the research found
Contracting muscles function as an endocrine organ, releasing signalling molecules called myokines that reach multiple tissues—brain, bone, adipose tissue, gut, and immune system among them. The critical mechanistic detail is that myokine release is contraction-dependent: a large muscle at rest produces no such signals, which means sedentary time negates potential benefits regardless of muscle mass.
The discussion distinguishes between interleukin-6 (IL-6) produced during muscle contraction and circulating IL-6 measured as a systemic inflammatory marker—these behave differently biologically. Muscle contraction also triggers endogenous GLP-1 release, activating the same hormonal pathway that pharmaceutical weight-loss interventions target. The evidence suggests intermittent-intensity walking produces greater metabolic benefit than steady-state walking at equivalent total energy expenditure.
Why it matters for you
If you're tracking inflammatory biomarkers (CRP, TNF-α, IL-6) or monitoring bone density, the implication is direct: three years of light daily walking without stimulus variation may not shift either. The myokine framework explains why. You need contraction diversity—resistance work to trigger signals that strengthen bone, interval walking to generate different signalling cascades than continuous steady-state movement, and sufficient frequency (movement on most days) because the signal stops when contraction stops.
For those using GLP-1 peptides or tracking glucose regulation, understanding that resistance and interval training naturally stimulate endogenous GLP-1 may inform how you structure training around peptide protocols. The practical takeaway: five movement days weekly, incorporating both resistance (for myokine signals that support bone and metabolic health) and varied-intensity walking, likely outperforms consolidating exercise into fewer, longer sessions. Breaking prolonged sitting also matters—it's not just total daily movement.
Caveats
- Educational summary rather than new primary research; specific effect sizes and mechanism validation not detailed
- The distinction between muscle-derived vs. systemic IL-6 is established science, but the clinical relevance for individual inflammatory marker interpretation remains context-dependent
- Exercise prescription recommendations (frequency, intensity structure) are evidence-informed but presented as framework rather than protocol—individual response varies
- No discussion of confounding factors (nutrition, sleep, stress) that modulate myokine signalling